← All trials
NCT06048614
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2023
- Primary completion
- Jul 31, 2026
- Completion date
- Dec 31, 2026
- First posted
- Sep 21, 2023
- Last posted
- Sep 22, 2023
- Enrollment
- 95
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- KK Women's and Children's HospitalLead sponsor
- Duke UniversityCollaborator
- National University of SingaporeCollaborator
- KK Women's and Children's HospitalReponsible party - principal investigator
- Singapore General HospitalCollaborator
- SingHealth Investigational Medicine UnitCollaborator
- KK Women's and Children's HospitalSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.